Updated:
AllerFund
AllerFund is the first venture capital firm dedicated to driving social impact for the food allergy community. Its team consists of operators, scientists and...
AllerFund
AllerFund is the first venture capital firm dedicated to driving social impact for the food allergy community. Its team consists of operators, scientists and food allergy parents committed to curing food allergies.
General information
Firm type
Private Equity
Year founded
2020
Location
Region
North America
Country
United States
City
New York
Corporate office
Scarsdale, United States
Principals
Lisa Strovink
Managing Partner
Adam Miller
Managing Partner
Christine Olsen
Founding Advisor
Lesley Solomon
Founding Advisor
Sector focus
Frequently asked questions
Who runs investment decisions at AllerFund?
No named principals or investment committee members are disclosed in public sources.
What asset classes does AllerFund deploy into?
The firm is recorded as focused on early stage private equity.
Does AllerFund publish AUM figures?
No AUM number is disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: